362 related articles for article (PubMed ID: 16777576)
21. Prevalence of inflammatory bowel disease in patients with airways disease.
Raj AA; Birring SS; Green R; Grant A; de Caestecker J; Pavord ID
Respir Med; 2008 May; 102(5):780-5. PubMed ID: 18321696
[TBL] [Abstract][Full Text] [Related]
22. Tumor necrosis factor-alpha antagonism improves endothelial dysfunction in patients with Crohn's disease.
Schinzari F; Armuzzi A; De Pascalis B; Mores N; Tesauro M; Melina D; Cardillo C
Clin Pharmacol Ther; 2008 Jan; 83(1):70-6. PubMed ID: 17507924
[TBL] [Abstract][Full Text] [Related]
23. Cancer and pediatric inflammatory bowel disease.
Kayton ML
Semin Pediatr Surg; 2007 Aug; 16(3):205-13. PubMed ID: 17602977
[TBL] [Abstract][Full Text] [Related]
24. Immunosuppression in inflammatory bowel disease: traditional, biological or both?
Van Assche G; Vermeire S; Rutgeerts P
Curr Opin Gastroenterol; 2009 Jul; 25(4):323-8. PubMed ID: 19417645
[TBL] [Abstract][Full Text] [Related]
25. Intestinal mucosal permeability in inflammatory rheumatic diseases. II. Role of disease.
Mielants H; De Vos M; Goemaere S; Schelstraete K; Cuvelier C; Goethals K; Maertens M; Ackerman C; Veys EM
J Rheumatol; 1991 Mar; 18(3):394-400. PubMed ID: 1906939
[TBL] [Abstract][Full Text] [Related]
26. Treatment of ankylosing spondylitis and extra-articular manifestations in everyday rheumatology practice.
Elewaut D; Matucci-Cerinic M
Rheumatology (Oxford); 2009 Sep; 48(9):1029-35. PubMed ID: 19561158
[TBL] [Abstract][Full Text] [Related]
27. Psoriasis induced by tumor necrosis factor-alpha antagonist therapy: a case series.
Cohen JD; Bournerias I; Buffard V; Paufler A; Chevalier X; Bagot M; Claudepierre P
J Rheumatol; 2007 Feb; 34(2):380-5. PubMed ID: 17013997
[TBL] [Abstract][Full Text] [Related]
28. Inflammatory bowel disease in children: a pediatrician's perspective.
Cuffari C
Minerva Pediatr; 2006 Apr; 58(2):139-57. PubMed ID: 16835574
[TBL] [Abstract][Full Text] [Related]
29. Differentiating ulcerative colitis from Crohn disease in children and young adults: report of a working group of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the Crohn's and Colitis Foundation of America.
; ; Bousvaros A; Antonioli DA; Colletti RB; Dubinsky MC; Glickman JN; Gold BD; Griffiths AM; Jevon GP; Higuchi LM; Hyams JS; Kirschner BS; Kugathasan S; Baldassano RN; Russo PA
J Pediatr Gastroenterol Nutr; 2007 May; 44(5):653-74. PubMed ID: 17460505
[TBL] [Abstract][Full Text] [Related]
30. HLA-B27 related arthritis and bowel inflammation. Part 2. Ileocolonoscopy and bowel histology in patients with HLA-B27 related arthritis.
Mielants H; Veys EM; Cuvelier C; De Vos M; Botelberghe L
J Rheumatol; 1985 Apr; 12(2):294-8. PubMed ID: 3875721
[TBL] [Abstract][Full Text] [Related]
31. [Colorectal cancer in inflammatory bowel disease].
Henriksen M; Moum B
Tidsskr Nor Laegeforen; 2007 Oct; 127(20):2696-9. PubMed ID: 17952155
[TBL] [Abstract][Full Text] [Related]
32. The frequency of sacroileitis and ankylosing spondylitis in inflammatory bowel disease and HLA-B27 association.
Türeyen A; Kayaçetin E; Naldöken S; Balci M; Ulker A
Turk J Gastroenterol; 2002 Sep; 13(3):125-9. PubMed ID: 16378292
[TBL] [Abstract][Full Text] [Related]
33. Ankylosing spondylitis and symptom-modifying vs disease-modifying therapy.
Akkoc N; van der Linden S; Khan MA
Best Pract Res Clin Rheumatol; 2006 Jun; 20(3):539-57. PubMed ID: 16777581
[TBL] [Abstract][Full Text] [Related]
34. Role of small-bowel endoscopy in the management of patients with inflammatory bowel disease: an international OMED-ECCO consensus.
Bourreille A; Ignjatovic A; Aabakken L; Loftus EV; Eliakim R; Pennazio M; Bouhnik Y; Seidman E; Keuchel M; Albert JG; Ardizzone S; Bar-Meir S; Bisschops R; Despott EJ; Fortun PF; Heuschkel R; Kammermeier J; Leighton JA; Mantzaris GJ; Moussata D; Lo S; Paulsen V; Panés J; Radford-Smith G; Reinisch W; Rondonotti E; Sanders DS; Swoger JM; Yamamoto H; Travis S; Colombel JF; Van Gossum A;
Endoscopy; 2009 Jul; 41(7):618-37. PubMed ID: 19588292
[TBL] [Abstract][Full Text] [Related]
35. Current dilemmas in the management of inflammatory bowel disease.
Rutgeerts P
Eur J Surg Suppl; 2002; (587):58-61. PubMed ID: 16144202
[TBL] [Abstract][Full Text] [Related]
36. Tumour necrosis factor inhibitors in ankylosing spondylitis.
Reed MR; Taylor AL
Intern Med J; 2008 Oct; 38(10):781-9. PubMed ID: 18422565
[TBL] [Abstract][Full Text] [Related]
37. Do Anti-TNF Agents Increase the Risk of Inflammatory Bowel Disease Evolution in Patients with Ankylosing Spondylitis? Real Life Data.
Üsküdar Cansu D; Üsküdar Teke H; Temel T; Ertürk A; Kahraman O; Korkmaz C
J Natl Med Assoc; 2019 Jun; 111(3):262-269. PubMed ID: 30389147
[TBL] [Abstract][Full Text] [Related]
38. [Association between membranous glomerulonephritis and Crohn's disease].
Díaz Rodríguez C; Granja E; Vázquez Martul E; Sacristán F; Moreno Fernández A; González Rivero C; del Río Romero D; Trinidad JC
Nefrologia; 2004; 24(4):368-71. PubMed ID: 15455498
[TBL] [Abstract][Full Text] [Related]
39. Systemic complications of inflammatory bowel disease.
Baillie J; Soltis RD
Geriatrics; 1985 Feb; 40(2):53-6, 59-60. PubMed ID: 3881318
[TBL] [Abstract][Full Text] [Related]
40. Mucosal healing in inflammatory bowel disease: results from a Norwegian population-based cohort.
Frøslie KF; Jahnsen J; Moum BA; Vatn MH;
Gastroenterology; 2007 Aug; 133(2):412-22. PubMed ID: 17681162
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
